Prognostic implications of trabecular complexity measured by fractal analysis in left ventricular noncompaction

Autor: Azpiroz Franch, M. J., Casas Masnou, G., Romero, A., Gonzalez Del Hoyo, M., I, Larranaga Moreira, J. M., Escalona Silva, R., Guala, A., Limeres Freire, J., Bayes Genis, A., Zorio Grima, E., Villacorta Arguelles, E., Garcia Pavia, P., Barriales Villa, R., Ferreira Gonzalez, I, Rodriguez Palomares, J. F.

Publikováno v: EUROPEAN HEART JOURNAL
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Introduction Left ventricular non compaction (LVNC) is a heterogeneous entity characterized by prominent LV trabeculae. Fractal analysis, a semi-automatic method to quantify the degree of hypertrabeculation, has been described as a diagnostic criteri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0722aa98a7f9aeb27b67f7a7c81eeddd
https://doi.org/10.1093/eurheartj/ehac544.255

Characterization of hereditary transthyretin cardiac amyloidosis in Spain

Autor: Álvarez Rubio J, Manovel Sánchez AJ, González-Costello J, García-Pavía P, Limeres Freire J, García-Pinilla JM, Zorio Grima E, García-Álvarez A, Valverde Gómez M, Espinosa Castro MÁ, Barge-Caballero G, Gimeno Blanes JR, Bosch Rovira MT, Rincón Díaz LM, Aibar Arregui MÁ, Gallego-Delgado M, Jiménez-Jáimez J, Martínez Moreno M, Basurte M, Arana Achaga X, Hernández Baldomero IF, Ripoll-Vera T, AC-TTRv-Spain Investigator Group

Publikováno v: Revista espanola de cardiologia (English ed.)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Hereditary transthyretin amyloidosis (hATTR) is a disease caused by mutations in the transthyretin gene that frequently shows cardiac involvement due to amyloid deposition in the myocardium. Our objective was to identify cardiac involvement in a Span

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::8ddaa143b806e56c45afa39e9f7f3b49
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15220

Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry.

Autor: Gimeno JR; Departamento de Medicina Interna, Universidad de Murcia, Ctra. Finca Buenavista s/n, Campus Ciencias de la Salud, El Palmar, Murcia, 30120, Spain.; European Reference Networks for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Amsterdam, The Netherlands.; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain., Olivotto I; Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy., Rodríguez AI; Departamento de Medicina Interna, Universidad de Murcia, Ctra. Finca Buenavista s/n, Campus Ciencias de la Salud, El Palmar, Murcia, 30120, Spain.; European Reference Networks for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Amsterdam, The Netherlands., Ho CY; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA., Fernández A; Unidad de Cardiopatías Familiares, Favaloro Foundation University Hospital, Buenos Aires, Argentina., Quiroga A; Unidad de Cardiopatías Familiares, Favaloro Foundation University Hospital, Buenos Aires, Argentina., Espinosa MA; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad de Cardiopatías Familiares, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Gómez-González C; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad de Cardiopatías Familiares, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Robledo M; Hospital Universitario Araba (Txagorritxu), Alava, Spain., Tojal-Sierra L; Hospital Universitario Araba (Txagorritxu), Alava, Spain., Day SM; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Owens A; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Barriales-Villa R; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad CSUR Cardiopatías Familiares, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain., Larrañaga JM; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad CSUR Cardiopatías Familiares, Complexo Hospitalario Universitario de A Coruña, A Coruña, Spain., Rodríguez-Palomares J; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., González-Del-Hoyo M; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Department of Cardiology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain., Piqueras-Flores J; Cardiac Department, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Reza N; Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA., Chumakova O; Municipal Clinical Hospital #17, Moscow, Russia., Ashley EA; Center for Inherited Heart Disease, Stanford University Medical Center, Stanford, CA, USA., Parikh V; Center for Inherited Heart Disease, Stanford University Medical Center, Stanford, CA, USA., Wheeler M; Center for Inherited Heart Disease, Stanford University Medical Center, Stanford, CA, USA., Jacoby D; Yale New Haven Hospital, New Haven, CT, USA., Pereira AC; Hospital das Clinicas da Univerisidade de Sao Paulo, Sao Paulo, Brazil., Saberi S; Department of Internal Medicine, University of Michigan Hospital, Ann Arbor, MI, USA., Helms AS; Department of Internal Medicine, University of Michigan Hospital, Ann Arbor, MI, USA., Villacorta E; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad de Cardiopatías Familiares, Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.; Gerencia Regional de Salud de Castilla y León (SACYL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain., Gallego-Delgado M; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad de Cardiopatías Familiares, Servicio de Cardiología, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain.; Gerencia Regional de Salud de Castilla y León (SACYL), Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain., de Castro D; European Reference Networks for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Amsterdam, The Netherlands.; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad CSUR/ERN Cardiopatias Familiares, Hospital Universitario Puerta Hierro Majadahonda, Madrid, Spain., Domínguez F; European Reference Networks for rare, low prevalence and complex diseases of the heart (ERN GUARD-Heart), Amsterdam, The Netherlands.; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad CSUR/ERN Cardiopatias Familiares, Hospital Universitario Puerta Hierro Majadahonda, Madrid, Spain., Ripoll-Vera T; Unidad Cardiopatias Familiares, Hospital Universitario Son Llàtzer, Mallorca, Spain., Zorio-Grima E; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad Cardiopatias Familiares, Hospital Universitario y Politécnico La Fe, Valencia, Spain., Sánchez-Martínez JC; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Unidad Cardiopatias Familiares, Hospital Universitario y Politécnico La Fe, Valencia, Spain., García-Álvarez A; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Arrhythmia Section, Cardiology Department, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Arbelo E; Center for Biomedical Network Research on Cardiovascular Diseases (CIBERCV), Madrid, Spain.; Arrhythmia Section, Cardiology Department, Hospital Clínic, University of Barcelona, Barcelona, Spain.; Institut d'Investigació August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Mogollón MV; Cardiac Department, Hospital San Pedro de Alcantara, Cáceres, Spain., Fuentes-Cañamero ME; Cardiac Department, Badajoz University Hospital, Badajoz, Spain., Grande E; Dilemma Solution S.L, A Coruña, Spain., Peña C; Dilemma Solution S.L, A Coruña, Spain., Monserrat L; Dilemma Solution S.L, A Coruña, Spain., Lakdawala NK; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.

Publikováno v: ESC heart failure [ESC Heart Fail] 2022 Aug; Vol. 9 (4), pp. 2189-2198. Date of Electronic Publication: 2022 Jun 03.

CardioGraph: a platform to study variations associated with familiar cardiopathies.

Autor: García S., Alberto¹ (AUTHOR) algarsi3@vrain.upv.es, Costa, Mireia¹ (AUTHOR), Perez, Ana¹ (AUTHOR), Pastor, Oscar¹ (AUTHOR)

Publikováno v: BMC Medical Informatics & Decision Making. 10/21/2024, Vol. 23, p1-24. 24p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.